<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
  • Menu
  • crown-logo-symbol-1-400x551

Find it Quickly!

Find it Quickly

Get Started

Select the option that best describes what you are looking for

  • Services
  • Models
  • Scientific Information

Search Here For Services

Click Here to Start Over

Search Here For Models

Click Here to Start Over

Search Here For Scientific Information

Click Here to Start Over

In Vitro

Boost oncology drug discovery with XenoBase®, featuring the largest cell line selection and exclusive 3D organoid models. Benefit from OrganoidXplore™ and OmniScreen™ for rapid, in-depth analysis.

Learn More

In Vivo

Enhance drug development with our validated in vivo models, in vitro/ex vivo assays, and in silico modeling. Tailored solutions to optimize your candidates.

Learn More

Tissue

Experience ISO-certified biobanking quality. Access top biospecimens from a global clinical network, annotated by experts for precise research.

Learn More

Biomarkers and Bioanalysis

Leverage our global labs and 150+ scientists for fast, tailored project execution. Benefit from our expertise, cutting-edge tech, and validated workflows for reliable data outcomes.

Learn More

Data Science and Bioinformatics

Harness your data and discover biomarkers with our top bioinformatics expertise. Maximize data value and gain critical insights to accelerate drug discovery and elevate projects.

Learn More

KRAS

Accelerate innovative cancer treatments with our advanced models and precise drug screening for KRAS mutations, efficiently turning insights into clinical breakthroughs.

Learn More

EGFR

Advance translational pharmacology with our diverse pre-clinical models, robust assays, and data science-driven biomarker analysis, multi-omics, and spatial biology.

Learn More

Drug Resistance

Our suite integrates preclinical solutions, bioanalytical read-outs, and multi-omics to uncover drug resistance markers and expedite discovery with our unique four-step strategy.

Learn More

Patient Tissue

Enhance treatments with our human tumor and mouse models, including xenografts and organoids, for accurate cancer biology representation.

Learn More

Bioinformatics

Apply the most appropriate in silico framework to your pharmacology data or historical datasets to elevate your study design and analysis, and to improve your chances of clinical success.

Learn More

Biomarker Analysis

Integrate advanced statistics into your drug development projects to gain significant biological insight into your therapeutic candidate, with our expert team of bioinformaticians.

Learn More

CRISPR/Cas9

Accelerate your discoveries with our reliable CRISPR solutions. Our global CRISPR licenses cover an integrated drug discovery platform for in vitro and in vivo efficacy studies.

Learn More

Genomics

Rely on our experienced genomics services to deliver high quality, interpretable results using highly sensitive PCR-based, real-time PCR, and NGS technologies and advanced data analytics.

Learn More

In Vitro High Content Imaging

Gain more insights into tumor growth and disease progression by leveraging our 2D and 3D fluorescence optical imaging.

Learn More

Mass Spectrometry-based Proteomics

Next-generation ion mobility mass spectrometry (MS)-based proteomics services available globally to help meet your study needs.

Learn More

Ex Vivo Patient Tissue

Gain better insight into the phenotypic response of your therapeutic candidate in organoids and ex vivo patient tissue.

Learn More

Spatial Multi-Omics Analysis

Certified CRO services with NanoString GeoMx Digital Spatial Profiling.

Learn More

Biomarker Discovery

De-risk your drug development with early identification of candidate biomarkers and utilize our biomarker discovery services to optimize clinical trial design.

Learn More

DMPK Services

Rapidly evaluate your molecule’s pharmaceutical and safety properties with our in vivo drug metabolism and pharmacokinetic (DMPK) services to select the most robust drug formulations.

Learn More

Efficacy Testing

Explore how the novel HuGEMM™ and HuCELL™ platforms can assess the efficacy of your molecule and accelerate your immuno-oncology drug discovery programs.

Learn More

Laboratory Services

Employ cutting-edge multi-omics methods to obtain accurate and comprehensive data for optimal data-based decisions.

Learn More

Pharmacology & Bioanalytical Services

Leverage our suite of structural biology services including, recombinant protein expression and protein crystallography, and target validation services including RNAi.

Learn More

Screens

Find the most appropriate screen to accelerate your drug development: discover in vivo screens with MuScreen™ and in vitro cell line screening with OmniScreen™.

Learn More

Toxicology

Carry out safety pharmacology studies as standalone assessments or embedded within our overall toxicological profiling to assess cardiovascular, metabolic and renal/urinary systems.

Learn More

Our Company

Global CRO in California, USA offering preclinical and translational oncology platforms with high-quality in vivo, in vitro, and ex vivo models.

Learn More

Our Purpose

Learn more about the impact we make through our scientific talent, high-quality standards, and innovation.

Learn More

Our Responsibility

We build a sustainable future by supporting employee growth, fostering leadership, and exceeding customer needs. Our values focus on innovation, social responsibility, and community well-being.

Learn More

Meet Our Leadership Team

We build a sustainable future by fostering leadership, employee growth, and exceeding customer needs with innovation and social responsibility.

Learn More

Scientific Advisory Board

Our Scientific Advisory Board of experts shapes our strategy and ensures top scientific standards in research and development.

Learn More

News & Events

Stay updated with Crown Bioscience's latest news, achievements, and announcements. Check our schedule for upcoming events and plan your visit.

Learn More

Career Opportunities

Join us for a fast-paced career addressing life science needs with innovative technologies. Thrive in a respectful, growth-focused environment.

Learn More

Scientific Publications

Access our latest scientific research and peer-reviewed articles. Discover cutting-edge findings and insights driving innovation and excellence in bioscience.

Learn More

Resources

Discover valuable insights and curated materials to support your R&D efforts. Explore the latest trends, innovations, and expertly curated content in bioscience.

Learn More

Blogs

Explore our blogs for the latest insights, research breakthroughs, and industry trends. Stay educated with expert perspectives and in-depth articles driving innovation in bioscience.

Learn More

  • Platforms
  • Target Solutions
  • Technologies
  • Service Types

Patient-Derived Xenograft Models of Pancreatic Cancer

Patient-derived xenograft (PDX) models provide a predictive preclinical model for the evaluation of an agent’s efficacy prior to entering the clinic. The Crown Bioscience pancreatic collection contains over 100 models, including models of both North American and Asian descent. More

Benefits of Crown Bioscience's Pancreatic Cancer PDX Models

Our pancreatic cancer patient-derived xenograft models offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, Patient derived xenografts reflect the heterogeneity and diversity of the human patient population. PDX will give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. Crown Bioscience's HuPrime® Pancreatic cancer PDX model collection is well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL NUMBER CANCER TYPE CANCER SUBTYPE DESCRIPTION # per page
PA0226 Pancreatic Cancer Adenocarcinoma N/A CLICK TO VIEW
PA0372 Pancreatic Cancer ADC Adenocarcinoma of right axillary region, poorly differentiated. Regional LN: right axillary LN (20/22). CLICK TO VIEW
PA0527 Pancreatic Cancer ADC Adenocarcinoma of head of pancreas. No malignant cells adjacent to both stump, duodenal wall and common bile duct. Regional LN: the eighth group LN (0/1), the twelfth group (0/1), posterior head of pancreatic LN (1/1). Chronic cholecystitis. CLICK TO VIEW
PA0573 Pancreatic Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
PA0692 Pancreatic Cancer ADC Moderately to poorly differentiated adenocarcinoma CLICK TO VIEW
PA0787 Pancreatic Cancer ADC Metastatic adenocarcinoma in LN, consider originate from pancreas. IHC results: CK(++), CK7(++), CK18(+), CK19(++), CK20(-), CK34(++), CEA(+), CA125(+), CA19-9(+), Ki67(++), AFP(-), Hepatocyte(+/-), Syn(-), Vimentin(-), LCA(+). CLICK TO VIEW
PA0968 Pancreatic Cancer ADC NA for clinical diagnosis info. CLICK TO VIEW
PA1168 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. Chronic cholecystitis. CLICK TO VIEW
PA1170 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. CLICK TO VIEW
PA1178 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma with part of mucinous adenocarcinoma of head of pancreas, moderately differentiated.tumor mass: 4cm x 3cm x 2cm, invaded duodenal mucosa. Regional LN: parapancreatic LN (4/6). Chronic cholecystitis. CLICK TO VIEW
PA1189 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated, tumor mass: 2cm x 1cm x 1cm, invaded choledochal wall and muscular layer of duodenum. Regional LN: parapancreatic LN: (0/8). Chronic cholecystitis. CLICK TO VIEW
PA1194 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately-poorly differentiated, tumor mass: 3cm x 3cm x 3cm, invaded nerve tissue, adipose tissue around pancreas. Regional LN: parapancreatic LN: (1/5). Chronic cholecystitis. CLICK TO VIEW
PA1198 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. Regional LN: parapancreatic LN (0/3), LN of hepatoduodenal ligament (0/9). Chronic cholecystitis. CLICK TO VIEW
PA1214 Pancreatic Cancer ADC Adenocarcinoma of head of pancreas, moderately differentiated, infiltrating through duodenal wall. Regional LN: paragastric LN (0/4). Chronic cholecystitis. CLICK TO VIEW
PA1221 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated, infiltrating duodenal muscularis mucosa. Regional LN: parapancreatic LN (1/2). Chronic cholecystitis. CLICK TO VIEW
PA1222 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. Regional LN: parapancreatic LN (2/3), LN of margo inferior pancreas (0/2). Chronic cholecystitis. CLICK TO VIEW
PA1226 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. Regional LN: parapancreatic LN (2/3), LN of margo inferior pancreas (0/2). Chronic cholecystitis. CLICK TO VIEW
PA1229 Pancreatic Cancer ADC Adenocarcinoma of head of pancreas, moderately-poorly differentiated. Intraductal papillary mucinous neoplasms of body of pancreas. CLICK TO VIEW
PA1233 Pancreatic Cancer Ductal adenocarcinoma 1.Ductal adenocarcinoma of body and tail of pancreas, moderately differentiated, tumor mass: 3 x 2 x 2cm. Regional LN: parapancreatic LN (0/3). 2.Chronic splenic congestion. CLICK TO VIEW
PA1252 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated, tumor mass: 2.5 x 2 x 2cm. Regional LN: parapancreatic-bile duct LN (1/20). CLICK TO VIEW
PA1265 Pancreatic Cancer ADC Adenocarcinoma of head of pancreas, moderately to poorly differentiated CLICK TO VIEW
PA1266 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of pancreas, poorly to moderately differentiated. Regional LN: parapancreatic LN (0/6), the other LN (1/1). Chronic cholecystitis. CLICK TO VIEW
PA1280 Pancreatic Cancer ADC Adenosquamous carcinoma of head of pancreas, moderately differentiated, tumor mass: 3 x 3 x 2cm, infiltrating nervus and duodenal submucosa. Regional LN: parapancreatic LN (0/3), postcaval LN (0/1), peripheral common hepatic arterial LN (0/1). Chronic cholecystitis. CLICK TO VIEW
PA1284 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of pancreas, moderately differentiated, invaded gastric wall, tumor mass: 3.5 x 3 x 2cm. Regional LN: parapancreatic LN (1/10). CLICK TO VIEW
PA1290 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated, invaded choledochal wall and nervus, tumor mass: 3.5 x 2 x 1.5cm. Regional LN: parapancreatic LN(5/5). CLICK TO VIEW
PA13004 Pancreatic Cancer NA Pancreatic carcinoma CLICK TO VIEW
PA1301 Pancreatic Cancer Ductal adenocarcinoma 1.Ductal adenocarcinoma of head of pancreas, moderately differentiated. Tumor tissue show infiltrative growth, infiltrating peripheral adipose tissue and duodenal muscular layer. Regional LN: peripancreatic LN (0/4). 2. Chronic cholecystitis. CLICK TO VIEW
PA13019 Pancreatic Cancer NA Pancreatic carcinoma CLICK TO VIEW
PA13021 Pancreatic Cancer NA Pancreatic carcinoma CLICK TO VIEW
PA13022 Pancreatic Cancer NA METASTATIC ADENOCARCINOMA, MPD CLICK TO VIEW
PA13024 Pancreatic Cancer NA Pancreatic carcinoma CLICK TO VIEW
PA13026 Pancreatic Cancer NA NA CLICK TO VIEW
PA13027 Pancreatic Cancer NA Pancreatic carcinoma CLICK TO VIEW
PA13031 Pancreatic Cancer ADC ADENOCARCINOMA CLICK TO VIEW
PA13033 Pancreatic Cancer NA Pancreatic Cancer CLICK TO VIEW
PA13035 Pancreatic Cancer NA Pancreatic Carcinoma CLICK TO VIEW
PA13037 Pancreatic Cancer NA Pancreatic carcinoma CLICK TO VIEW
PA13039 Pancreatic Cancer NA Pancreatic carcinoma CLICK TO VIEW
PA1306 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of body and tail of pancreas, moderately differentiated, tumor mass: 6 x 4 x 3cm. Regional LN: parapancreatic LN (1/6), splenic hilar LN (0/2), celiac trunk LN (0/1). CLICK TO VIEW
PA1316 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of body and tail of pancreas, moderately differentiated, tumor mass: 4 x 4 x 2cm. Massive tumor nodules were present. Regional LN: LN of lesser curvature (2/5). Chronic splenic congestion. CLICK TO VIEW
PA1322 Pancreatic Cancer ADC Adenocarcinoma of duodenum, poorly to moderately differentiated, invaded pancreas. Molecular pathology classified the model as pancreatic cancer. CLICK TO VIEW
PA1332 Pancreatic Cancer Adenosquamous carcinoma Adenosquamous carcinoma of head of pancreas, infiltrating nervus, tumor mass: 3 x 2 x 1.5cm. Regional LN: LN of lesser curvature (4/7). Chronic cholecystitis. CLICK TO VIEW
PA1333 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, poorly differentiated. Chronic cholecystitis. CLICK TO VIEW
PA1336 Pancreatic Cancer Ductal adenocarcinoma NA CLICK TO VIEW
PA1337 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. CLICK TO VIEW
PA1338 Pancreatic Cancer ADC Adenosquamous carcinoma of head of pancreas, tumor mass: 4 x 2.5 x 2.5cm, infiltrating nervus and parapancreatic adipose tissue. Regional LN: parapancreatic LN (3/7). CLICK TO VIEW
PA1357 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of body and tail of pancreas, moderately differentiated. CLICK TO VIEW
PA1360 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of body and tail of pancreas, moderately differentiated. Chronic splenic congestion. CLICK TO VIEW
PA1367 Pancreatic Cancer ADC Adenosquamous carcinoma of pancreas. Chronic cholecystitis. CLICK TO VIEW
PA1373 Pancreatic Cancer Adenocarcinoma NA CLICK TO VIEW
PA1383 Pancreatic Cancer ADC Neuroendocrine carcinoma of body and tail of pancreas, well differentiated. CLICK TO VIEW
PA1390 Pancreatic Cancer ADC Adenosquamous carcinoma of body and tail pancreas, moderately differentiated. CLICK TO VIEW
PA13941 Pancreatic Cancer Mucinous adenocarcinoma N/A CLICK TO VIEW
PA13946 Pancreatic Cancer NA Metastatic pancreatic carcinoma. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK SECTION AND CYTOSPIN PREP. CLICK TO VIEW
PA13947 Pancreatic Cancer NA Pancreatic carcinoma. Pathol comment: C/W DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
PA1405 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. Tumor tissue show infiltrative growth, infiltrating nervous, duodenal muscular layer and duodenal papilla. Regional LN: parapancreatic LN (3/3), LN of ligamentum hepatoduodenale (0/1). CLICK TO VIEW
PA1413 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of body and tail of pancreas, moderately differentiated. CLICK TO VIEW
PA1443 Pancreatic Cancer ADC Metastatic adenocarcinoma of greater omentum and napes, poorly differentiated. Greater omental nodules include four tumor nodules, napes nodules have one tumor nodule. Tumor cells show cubical and polygon with the nuclear atypia. The tumor forms tubular and cribriform structures and has an infiltrative growth pattern. CLICK TO VIEW
PA1455 Pancreatic Cancer Ductal adenocarcinoma of head of pancreas, moderately differentiated. Chronic cholecystitis. CLICK TO VIEW
PA1457 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. Chronic cholecystitis. CLICK TO VIEW
PA1459 Pancreatic Cancer ADC Adenosquamous carcinoma of pancreas. Chronic cholecystitis. CLICK TO VIEW
PA15055 Pancreatic Cancer N/A N/A CLICK TO VIEW
PA1644 Pancreatic Cancer Mucinous adenocarcinoma Mucinous adenocarcinoma CLICK TO VIEW
PA2020 Pancreatic Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
PA2021 Pancreatic Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
PA2022 Pancreatic Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
PA2023 Pancreatic Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
PA2031 Pancreatic Cancer NA Infiltrating duct carcinoma, NOS CLICK TO VIEW
PA2035 Pancreatic Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
PA2078 Pancreatic Cancer ADC Pancreatic Adenocarcinoma CLICK TO VIEW
PA2081 Pancreatic Cancer ADC Pancreatic Adeno Carcinoma CLICK TO VIEW
PA2405 Pancreatic Cancer ADC Pancreatic well differentiated adenocarcinoma CLICK TO VIEW
PA2406 Pancreatic Cancer ADC Pancreas: adenocarcinoma, site of metastasis: Omental and diaphragmatic nodules CLICK TO VIEW
PA2409 Pancreatic Cancer ADC Pancreatic adenocarcinoma, poorly differentiated CLICK TO VIEW
PA2410 Pancreatic Cancer ADC Adenocarcinoma CLICK TO VIEW
PA2414 Pancreatic Cancer ADC Poorly differentiated adenocarcinoma CLICK TO VIEW
PA2415 Pancreatic Cancer Mucinous adenocarcinoma Pancreatic Ductal adenocarcinoma, mucinous adenocarcinoma CLICK TO VIEW
PA2416 Pancreatic Cancer ADC Pancreatic ductal adenocarcinoma CLICK TO VIEW
PA2424 Pancreatic Cancer Mucinous adenocarcinoma NA for clinical diagnosis info. CLICK TO VIEW
PA2425 Pancreatic Cancer ADC NA for clinical diagnosis info. CLICK TO VIEW
PA2426 Pancreatic Cancer ADC NA for clinical diagnosis info. CLICK TO VIEW
PA2450 Pancreatic Cancer ADC Head of pancreas: ductal adenocarcinoma, moderately differentiated. CLICK TO VIEW
PA2451 Pancreatic Cancer ADC Head of pancreas: ductal adenocarcinoma, poorly differentiated. CLICK TO VIEW
PA2454 Pancreatic Cancer Mucinous adenocarcinoma Adenocarcinoma, NOS CLICK TO VIEW
PA2507 Pancreatic Cancer ADC NA for clinical diagnosis info. Molecular pathology (RNAseq based) classification as a pancreatic cancer model. CLICK TO VIEW
PA2562 Pancreatic Cancer ADC NA for clinical diagnosis info. CLICK TO VIEW
PA2566 Pancreatic Cancer Adenocarcinoma NA CLICK TO VIEW
PA2847 Pancreatic Cancer N/A N/A CLICK TO VIEW
PA3003 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of body and tail of pancreas, with part of signet ring cell carcinoma, poorly differentiated. The tumor forms irregular glandular or funicular structures and has an infiltrative growth pattern. Regional LN: peripancreatic LN (0/3). CLICK TO VIEW
PA3004 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated, tumor mass: 3.5 X 1.5cm. Regional LN: inferior pancreatic LN: (0/1). Chronic cholecystitis. Chronic appendicitis. CLICK TO VIEW
PA3006 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of pancreas, moderately differentiated. CLICK TO VIEW
PA3008 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of body and tail of pancreas, moderately differentiated. Chronic cholecystitis. CLICK TO VIEW
PA3010 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of body and tail of pancreas, moderately differentiated. CLICK TO VIEW
PA3013 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of body and tail of pancreas, moderately to poorly differentiated. CLICK TO VIEW
PA3023 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. CLICK TO VIEW
PA3029 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately to poorly differentiated. CLICK TO VIEW
PA3060 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately to poorly differentiated. Chronic cholecystitis, cholelithiasis. CLICK TO VIEW
PA3065 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. Chronic cholecystitis. CLICK TO VIEW
PA3100 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. CLICK TO VIEW
PA3108 Pancreatic Cancer Ductal adenocarcinoma Head of pancreas: ductal adenocarcinoma, moderately to poorly differentiated. CLICK TO VIEW
PA3126 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately to poorly differentiated. Chronic cholecystitis CLICK TO VIEW
PA3127 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of body and tail of pancreas, poorly differentiated. Chronic splenic congestion. CLICK TO VIEW
PA3136 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of uncinate process of pancreas, moderately to poorly differentiated. Chronic cholecystitis. Regional LN: peripancreatic LN (1/4), LN of superior and posterior head of pancreas (1/1), LN of inferior and left head of pancreas(4/5), paraSMA(1/1), lateral common hepatic arterial LN (0/1), lateral arteria coeliaca LN (0/1), lateral portal vein LN (0/1), lateral proper hepatic arterial LN(0/1), root SMA(0/2), jejunal mesenteric LN (0/3), LN of lateral middle colic artery (0/3), lateral abdominal aorta LN (0/1), right celiac LN (0/1). CLICK TO VIEW
PA3137 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. The tumor forms irregular glandular or cribriform structures and has an infiltrative growth pattern. Regional LN: peripancreatic LN (0/6).Chronic cholecystitis. CLICK TO VIEW
PA3139 Pancreatic Cancer ADC Adenocarcinoma of head of pancreas, moderately to poorly differentiated.The tumor forms irregular glandular or nest structures and has an infiltrative growth pattern. Chronic cholecystitis with cholesterosis. Regional LN: peripancreatic LN (0/5). CLICK TO VIEW
PA3142 Pancreatic Cancer Adenosquamous carcinoma Adenosquamous carcinoma of body and tail of pancreas. The tumor forms irregular glanduar, cribriform or nest structues and has an infiltrative growth pattern. Keratinization and massive necrosis may be seen. Regional LN: peripancreatic LN (1/1). CLICK TO VIEW
PA3149 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. Chronic cholecystitis CLICK TO VIEW
PA3314 Pancreatic Cancer Ductal adenocarcinoma Head pancreas: poorly differentiated ductal adenocarcinoma CLICK TO VIEW
PA3546 Pancreatic Cancer NA Diaphragm: metastatic or invasive acinar cell carcinoma of the pancreas CLICK TO VIEW
PA4007 Pancreatic Cancer NA NA CLICK TO VIEW
PA5312 Pancreatic Cancer ADC pancreatic adenocarcinoma. Pathol comment: approximately 70% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
PA5313 Pancreatic Cancer NA Pancreatic Carcinoma. Pathol comment: c/w diagnosis. approximately 40% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
PA5363 Pancreatic Cancer ADC Pancreatic Carcinoma, Adenocarcinoma. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
PA5364 Pancreatic Cancer ADC Pancreatic Carcinoma, Adenocarcinoma. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
PA5365 Pancreatic Cancer ADC Pancreatic Carcinoma, Adenocarcinoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. APPROXIMATELY 60% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
PA5366 Pancreatic Cancer NA Pancreatic Carcinoma. Pathol comment: MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK. APPROXIMATELY 70% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. C/W DIAGNOSIS. CLICK TO VIEW
PA5379 Pancreatic Cancer NA Pancreatic Carcinoma. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
PA5389 Pancreatic Cancer NA Pancreatic Carcinoma. Pathol comment: MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. C/W DIAGNOSIS. CLICK TO VIEW
PA5402 Pancreatic Cancer NA Pancreatic Carcinoma. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
PA5403 Pancreatic Cancer NA Pancreatic Carcinoma. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK SECTION AND CYTOSPIN PREP. CLICK TO VIEW
PA5404 Pancreatic Cancer NA Pancreatic Carcinoma. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
PA5410 Pancreatic Cancer NA Pancreatic Carcinoma. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
PA5411 Pancreatic Cancer ADC Pancreatic Carcinoma; MUCINOUS ADENOCARCINOMA, WD. Pathol comment: C/W DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. CLICK TO VIEW
PA5412 Pancreatic Cancer NA Pancreatic Carcinoma. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK. RARE MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
PA5415 Pancreatic Cancer NA H/O Pancreatic Carcinoma. Pathol comment: MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK. C/W ADENOCARCINOMA. APPROXIMATELY 50% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
PA6213 Pancreatic Cancer ADC moderately to poorly differentiated adenocarcinoma, infiltrating to serosa. Eight of eight lymph nodes involved by metastatic carcinoma (8/8). CLICK TO VIEW
PA6228 Pancreatic Cancer Ductal adenocarcinoma Moderately to poorly differentiated ductal adenocarcinoma of pancreas with perineural infiltration, all lymph nodes are benign (0/3) CLICK TO VIEW
PA6230 Pancreatic Cancer ADC Moderately differentiated ductal adenocarcinoma of body and tail of pancreas, all lymph nodes are benign (0/4). Immunopathogenesis: TopoII was expressed at lower level. CLICK TO VIEW
PA6231 Pancreatic Cancer N/A N/A CLICK TO VIEW
PA6233 Pancreatic Cancer NA Intraductal papillary mucinous neoplasms of pancreas, with part of epithelial atypical hyperplasia. CLICK TO VIEW
PA6236 Pancreatic Cancer NA Carcinoma of pancreas CLICK TO VIEW
PA6237 Pancreatic Cancer Adenosquamous carcinoma Adenosquamous carcinoma of body of pancreas (adenocarcinoma: grade II, squamous cell carcinoma: grade II-III). Tumor invaded to fat tissue around pancreas, all lymph nodes are benign (0/10). CLICK TO VIEW
PA6238 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, grade II-III, infiltrating to duodenal submucosa. No lymph node involved by metastatic carcinoma (0/6). CLICK TO VIEW
PA6245 Pancreatic Cancer ADC Poorly differentiated ductal adenocarcinoma of head of pancreas, infiltrating to duodenal wall. Four of four lymph nodes involved by metastatic carcinoma (4/4). CLICK TO VIEW
PA6246 Pancreatic Cancer ADC Poorly differentiated ductal adenocarcinoma of body and tail of pancreas, infiltrating to fatty tissue around pancreas. Tumor mass: 3 x 3 x 1.5cm. CLICK TO VIEW
PA6247 Pancreatic Cancer ADC Moderately to poorly differentiated ductal adenocarcinoma of pancreas, infiltrating to duodenal deep muscularis. CLICK TO VIEW
PA6258 Pancreatic Cancer Adenosquamous carcinoma Adenosquamous carcinoma of head of pancreas, infiltrating to submucosa of intestinal wall and mucous layer of common bile duct. CLICK TO VIEW
PA6259 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, moderately differentiated. CLICK TO VIEW
PA6260 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of heade of pancreas, moderately differentiated. CLICK TO VIEW
PA6261 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas CLICK TO VIEW
PA6262 Pancreatic Cancer ADC Adenocarcinoma of body pancreas, moderately differentiated. CLICK TO VIEW
PA6263 Pancreatic Cancer ADC Adenocarcinoma of pancreas, grade II, infiltrating to peripheral fat tissue. CLICK TO VIEW
PA6265 Pancreatic Cancer Ductal adenocarcinoma Moderately differentiated ductal adenocarcinoma of body and tail of pancreas. CLICK TO VIEW
PA6270 Pancreatic Cancer Ductal adenocarcinoma Ductal adenocarcinoma of head of pancreas, grade II, infiltrating to duodenal mucosa. CLICK TO VIEW
PA6271 Pancreatic Cancer Ductal adenocarcinoma Uncinate process of pancreas: moderately differentiated ductal adenocarcinoma CLICK TO VIEW
PA6284 Pancreatic Cancer Ductal adenocarcinoma Body and tail of pancreas: ductal adenocarcinoma, moderately differentiated CLICK TO VIEW
PA6285 Pancreatic Cancer Ductal adenocarcinoma Body and tail of pancreas: ductal adenocarcinoma CLICK TO VIEW
PA9435 Pancreatic Cancer NA Ductal adenocarcinoma CLICK TO VIEW
PA9440 Pancreatic Cancer NA NA CLICK TO VIEW
PA9442 Pancreatic Cancer NA NA CLICK TO VIEW
PA9444 Pancreatic Cancer NA NA CLICK TO VIEW
PA9445 Pancreatic Cancer Adenocarcinoma NA CLICK TO VIEW
PA9446 Pancreatic Cancer NA NA CLICK TO VIEW
PA9447 Pancreatic Cancer NA NA CLICK TO VIEW
PA9451 Pancreatic Cancer NA NA CLICK TO VIEW
PA9453 Pancreatic Cancer N/A N/A CLICK TO VIEW
PA9454 Pancreatic Cancer N/A N/A CLICK TO VIEW

Sorry, no posts matched your criteria.

Create Account to View All Model Data

Already Registered? Login